Preprint
Case Report

This version is not peer-reviewed.

Integrating Telerehabilitation into the Prehabilitation and Rehabilitation Pathway in Colorectal Cancer: A Cases Series

A peer-reviewed article of this preprint also exists.

Submitted:

07 April 2025

Posted:

08 April 2025

You are already at the latest version

Abstract
Background and Clinical Significance: Colorectal cancer (CRC) remains a global health challenge with significant postoperative complications and functional declines. Telerehabilitation offers an accessible alternative to improve preoperative physical condition and postoperative recovery. Case Presentation: Five CRC patients scheduled for laparoscopic surgery participated in an asynchronous telerehabilitation multimodal program, including two weeks of prehabilitation and four weeks of postoperative rehabilitation. Delivered via a digital platform with remote physiotherapist support, the intervention improved functional capacity and muscle strength preoperatively, with partial recovery noted post-surgery. Conclusions: Integrating telerehabilitation into the CRC surgical pathway is feasible and may enhance functional outcomes and quality of life. Further studies are required to confirm these preliminary findings.
Keywords: 
;  ;  ;  ;  

1. Introduction and Clinical Significance

Colorectal cancer (CRC) remains a significant global public health challenge due to its high incidence, substantial mortality rate, and considerable healthcare burden. According to the World Health Organization (WHO), CRC is the third most commonly diagnosed cancer worldwide, accounting for approximately 10% of all cancer cases, and remains the second leading cause of cancer-related mortality [1]
Preventive strategies for CRC primarily target modifiable lifestyle factors, including smoking, alcohol consumption, sedentary behavior, obesity and poor dietary habits. In addition, promoting protective behaviors such as regular physical activity and a balanced diet play a crucial role in reducing CRC risk [2]. Screening programs serve as a key component of secondary prevention, enabling early detection and contributing to lower incidence and mortality rates [3].
Despite considerable advances in cancer therapies that have significantly improved survival rates and reduced the rate of local recurrence in CRC [4], functional outcomes have not improved at the same pace. Surgical resection, the primary curative approach for CRC, is often associated with significant postoperative morbidity, a prolonged recovery period and a noticeable reduction in functional capacity and quality of life (QoL) [5,6]. These postoperative complications often lead to loss of independence, increased healthcare utilization and increased healthcare costs. In addition, preoperative factors such as fatigue, muscle weakness, malnutrition and reduced physical capacity have been associated with higher complication rates, longer hospital stays and greater functional limitations [7,8]. Given these challenges, the integration of structured rehabilitation programs both preoperatively (prehabilitation) and postoperatively is essential to optimize functional recovery, reduce postoperative complications, minimize healthcare costs, and improve long-term patient outcomes [9] .
Exercise and rehabilitation are fundamental components of comprehensive cancer care, as recommended in international guidelines [10,11]. Multimodal prehabilitation, which includes structured physical exercise, nutritional optimization, and therapeutic education, has been shown to significantly improve preoperative functional capacity, reduce postoperative complications, and accelerate recovery in patients undergoing CRC surgery [12,13,14]. Similarly, postoperative exercise interventions are essential for restoring physical function, promoting recovery and significantly improving overall QoL [14,15]. The integration of multimodal prehabilitation with Enhanced Recovery After Surgery (ERAS) protocols, standardized strategies to minimize surgical stress, further enhances these benefits by optimizing clinical outcomes, shortening hospital stays, and reducing healthcare costs [16,17,18].
Telerehabilitation has recently emerged as an innovative strategy to improve access to rehabilitation services. By using digital platforms to provide structured exercise programs, educational resources, and remote patient monitoring, telerehabilitation offers greater accessibility, flexibility, and treatment adherence compared to traditional in-person rehabilitation [19,20,21] [16]. This approach is particularly beneficial for patients with mobility limitations or those living in geographically remote areas [22]. In oncology, telerehabilitation has shown significant potential to increase patient engagement, maintain functional recovery and enhancing QoL, highlighting its valuable role in perioperative care and long-term CRC management [23].
As CRC incidence continues to rise, the need for accessible and effective rehabilitation strategies becomes increasingly relevant. While conventional rehabilitation programs have shown benefits, their availability and patient adherence remain challenging. Telerehabilitation presents a flexible and scalable alternative that could help overcome these barriers by providing remote access to structured interventions tailored to patients' needs.
The aim of this study is to evaluate the impact of an asynchronous multimodal telerehabilitation program on key clinical outcomes such as body composition, functional capacity, muscle strength, psychosocial factors and QoL in patients undergoing CRC surgery.

2. Case Presentation

This prospective case series describes five CRC patients who participated in a structured telerehabilitation program integrated into a multimodal prehabilitation strategy prior to CRC surgery, followed by a postoperative rehabilitation phase to improve functional recovery. The intervention was delivered asynchronously via a digital platform with remote monitoring.
The study was conducted between June 2024 and February 2025. Patients were recruited at the Department of General and Digestive Surgery of the Royo Villanova Hospital (Zaragoza, Spain). Ethical approval for the study protocol was granted by the Ethics Committee of Aragón under reference PI23/557. All participants provided written informed consent prior to enrolment, in accordance with the ethical standards before participating in the study.

2.1. Eligibility Criteria

The inclusion criteria were: 1) Adults aged 18 to 80 years; 2) Patients scheduled for elective CRC surgery at the Hospital Royo Villanova; 3) First consultation at the Department of General and Digestive Surgery; 4) Functionally independent individuals able to perform walking and pulmonary function tests; 5) Preoperative classification of I, II or III according to the American Society of Anaesthesiologists (ASA) classification and 6) Willingness to participate in the study and signed informed consent.
The exclusion criteria were: 1) Patients over 80 years old; 2) Preoperative ASA classification of IV; 3) Musculoskeletal, inflammatory or other pathological conditions prevent physical exercise; 4) Central and/or peripheral neurological disorders that limit participation in the rehabilitation program; 5) Unstable concomitant cardiac conditions, including arrhythmias, hypertension, angina, or other conditions contraindicating moderate-intensity exercise; 6) Diagnosed psychiatric disorders as determined by a psychiatrist; 7) Lack of access to an internet-enabled mobile device or computer at home and 8) Refusal to participate or lack of a signed consent form.

2.2. Cases Characteristics

The sample consisted of five adults (three males and two females) with a mean age of 53.6 ± 10.7 years (range: 36–62 years). Participants' weight ranged from 53.4 kg to 95.6 kg, with heights varying between 164 cm and 191 cm. Body mass index (BMI) assessments revealed that three participants were classified as overweight (BMI: 25.7–29.8 kg/m²), while two participants fell into the normal weight category (BMI: 20.6 and 20.8 kg/m²).
Educational backgrounds were diverse, including two participants with university degrees, two with secondary education, and one with primary education. All participants were employed during the study period.
The sociodemographic data collected are listed in Table 1 [25].

2.3. Procedure

After the recruitment of participants by the head of oncology at Royo Villanova Hospital, the physiotherapist in charge of the assessment visited Royo Villanova Hospital to conduct the initial and final assessments.
In the initial phase, the participants completed the written scales and followed the physical examination. Once the initial assessment was completed, the physiotherapist in charge of the intervention registered each patient in HEFORA.
HEFORA is a free, asynchronous digital platform for therapeutic exercise prescription and patient education that provides individualized instruction on their use. HEFORA enables remote monitoring and is accessible via mobile phone, tablet or computer and offers flexible participation options.
The physiotherapist installed the platform on each participant’s device and guided them through the navigation, self-monitoring features, and communication tools.
After completion of the onboarding, data collection was conducted at five key time points: Time 1 (T1): pre-prehabilitation (baseline assessment); Time 2 (T2): post-prehabilitation (pre-surgery, the day before surgery); Time 3 (T3): pre-rehabilitation (post-surgery – day 21, after suture removal); Time 4 (T4): post-rehabilitation (day 50, after completion of the rehabilitation phase); and Time 5 (T5): follow-up (three months after T4 by telephone assessment).

2.4. Intervention

The intervention was developed as part of a six-week telerehabilitation program, structured into two weeks of prehabilitation and four weeks of postoperative rehabilitation, in accordance with international rehabilitation guidelines [10,11,24].
The prehabilitation period was limited to two weeks due to the scheduling protocols within the public healthcare system, which define the available timeframe prior to elective colorectal cancer surgery. During this period, all participants followed the ERAS protocol [18], which encompasses preoperative patient education (including information about the surgical procedure, postoperative expectations, and self-care recommendations), perioperative optimization (including medication review, nutritional assessment, and interventions aimed at improving overall health status before surgery), and a structured preoperative exercise program to enhance aerobic capacity, muscle function, and mobility, factors that may aid in postoperative recovery through early mobilization. Furthermore, participants were prescribed a low-fibre diet in the 8 days leading up to surgery to minimize intestinal residue, improve surgical field visibility, and reduce the risk of postoperative complications.
Within the ERAS protocol, the physiotherapy team implemented the intervention in this case of series by leading a comprehensive therapeutic exercise program during both the prehabilitation and post-surgery rehabilitation phases.
The physiotherapy program included: 1) Therapeutic education: Participants received prerecorded videos and written materials with evidence-based guidance on prehabilitation principles, postoperative self-care, healthy lifestyle habits, and early mobilization strategies aimed at preventing complications and promoting autonomy during recovery. 2) Respiratory exercises: A daily respiratory program including diaphragmatic and costal expansion breathing, controlled breathing techniques and incentive spirometry was prescribed to enhance pulmonary function and reduce postoperative respiratory complications. 3) Aerobic exercise: Moderate to vigorous aerobic exercise totaling 150–300 minutes per week was recommended with the aim of gradually improving cardiovascular endurance and overall physical condition. 4) Strength training: Resistance exercises for the major muscle groups were performed at least four times per week. Intensity gradually increased from 3 sets of 8 repetitions to 3 sets of 15 repetitions, maintaining a perceived exertion level between 3 and 7 on the Borg scale to ensure safe and effective progression. This was guaranteed by the messaging system integrated into the platform that allowed participants to engage directly with the physiotherapist, providing personalized support, real-time feedback and program adjustments as needed. Adherence to the program was also monitored via the platform, with patients required to indicate whether they had completed the exercises or why they had not.

2.5. Outcomes

2.5.1. Primary Outcome

Functional capacity was assessed using the six-minute walk test (6MWT), according to the American Thoracic Society (ATS) and the European Respiratory Society (ERS) guidelines [25,26]. The test measures the maximum distance (meters) a patient can walk in six minutes along a standardized 30-meter corridor, providing an objective assessment of aerobic endurance, cardiopulmonary function, and overall physical capacity [27].
The 6MWT is widely used in colorectal cancer rehabilitation, as it assesses the patient's postoperative recovery and functional progress [28]. This test integrates the responses of the cardiovascular, pulmonary, and musculoskeletal systems, making it a reliable indicator of functional performance over time [29].

2.5.2. Secondary Outcomes

2.5.2.1. Body Composition

Body composition was determined using bioelectrical impedance analysis (BIA) with a Tanita BC-601 (InnerScan®V, Japan), a validated, non-invasive method for estimating visceral fat percentage, weight, body fat percentage, muscle mass and body water percentage [30]. The BIA method is widely used in clinical and research settings due to its reproducibility and ability to monitor longitudinal changes in body composition [31]. These parameters provide a comprehensive overview of metabolism, muscle condition and fat distribution, all of which are critical for the assessment of nutritional status and functional outcomes in CRC patients.
Waist and hip circumference were also measured according to a standardized anthropometric protocol to assess central adiposity, which is strongly associated with metabolic risk, systemic inflammation, and cancer prognosis [30]. In CRC rehabilitation, these indicators are particularly relevant, as increased visceral fat and sarcopenia have been associated to poorer functional outcomes, higher postoperative complication rates, and delayed recovery [32].

2.5.2.2. Muscle Strength

Muscle strength was assessed using two validated functional tests: the Handgrip Strength Test (HGS) for upper limb strength and the Five-Repetition Sit-to-Stand Test (5R-STS) for lower limb function. Both tests are commonly used in oncologic rehabilitation to evaluate neuromuscular performance, functional independence, and postoperative recovery [33].
Upper limb strength was measured using a hydraulic hand-held dynamometer in a standardized seated position (shoulder aligned, elbow at 90°, wrist in neutral position). Each patient performed three maximal voluntary contractions per hand, held for three seconds, and the highest value was used for analysis. Handgrip strength is a recognized marker of sarcopenia, recovery ability, and surgical outcome, with lower values associated with increased postoperative complications [34].
Lower limb strength was evaluated using the 5R-STS, which required patients to stand up and sit down five times as quickly as possible with their arms crossed over the chest. The total time (in seconds) was recorded, using a standardized chair height (43–47 cm) for consistency. This test is closely related to functional mobility, fall risk and postoperative recovery [35].

2.5.2.3. Psychosocial Factors

The Mental Adjustment to Cancer (MAC) questionnaire evaluates patients’ psychological adjustment to cancer using various cognitive-behavioral coping styles. Higher scores on Positive Adjustment dimensions (e.g., Fighting Spirit, Positive Orientation to the Illness) indicate active and adaptive coping, which is generally associated with better psychological well-being and better adherence to treatment. In contrast, elevated scores on Negative Adjustment dimensions (e.g., Help-less–Hopelessness, Anxious Preoccupation, Fatalism) suggest maladaptive responses, such as emotional distress, avoidance or resignation, which are associated with poorer QoL and prognosis [36,37].
The Hospital Anxiety and Depression Scale (HADS) is a validated instrument for assessing clinically relevant anxiety symptoms (HADS-A) and depression (HADS-D) and is commonly used in oncology to evaluate psychological distress and its impact on QoL and treatment adherence [38]. It comprises 14 items that are evenly divided into two subscales, each of which can be scored from 0 to 3, so that the total subscale scores range from 0 to 21. The generally accepted interpretation thresholds are: 0–7 (normal), 8–10 (borderline or mild symptoms) and ≥11 (probable clinical case). In cancer patients, elevated HADS scores have been consistently associated with decreased QoL, increased emotional distress, and decreased adherence to treatment. Accordingly, interpretation of scores should be placed in the context of the patient’s overall clinical profile, and elevated scores should lead to a more comprehensive psychosocial assessment and targeted psychological or emotional support interventions as appropriate [39].

2.5.2.4. Quality of Life EuroQol 5D

Health-related quality of life (HRQoL) was assessed using the EuroQol-5D (EQ-5D) questionnaire, a standardized, self-administered instrument widely used in both clinical practice and research to evaluate overall health status and patient-reported outcomes. Consists of two subscales: the EQ-5D descriptive system and the EQ visual analogue scale (EQ-VAS). The EQ-5D descriptive system includes five core dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is scored on five levels (EQ-5D-5L), allowing for a more detailed assessment of functional and psychological well-being [38]. The combination of scores for the five dimensions results in a five-digit code representing the person’s health profile, which is then converted into a utility index (EQ-5D index) ranging from 0.000 (equivalent to death) to 1.000 (perfect health). In addition, the EQ-VAS records the patient’s self-rated health on a scale from 0 (worst imaginable state of health) to 100 (best imaginable state of health), which is a subjective measure of perceived health [40].
In the context of oncology rehabilitation, particularly in the treatment of CCR patients, the EQ-5D is often used to monitor changes in physical functioning, symptom burden and emotional state to provide a comprehensive understanding of the impact of treatment and recovery [41].

2.6. Results

  • Functional Capacity
All participants improved their functional capacity as measured by the 6MWT during the prehabilitation phase, with participant 3 reporting the greatest improvement. In general, all participants exhibited a preoperative increase of 118.8 meters (21.3%) from T1 (557.2 ± 47.0 m) to T2 (676.0 ± 33.6 m) (Table 2).
After surgery, a post-surgery decline was observed in all participants between T2 and T3 (127.4 meters) (18.8%) (Table 2).
In the final assessment at T4, all participants improved compared to T3 (Median 54 meters), with participant 2 improving the most. In addition, only participants 1, 3, and 4 showed an increase in meters compared to the baseline values (Table 2).
  • Body composition
Changes in body composition (Table 3) reflected the combined effects of prehabilitation, surgery, rehabilitation, and dietary reintroduction.
With regard to the waist circumference, all participants except participant 2 reduced their circumference during the prehabilitation phase and after surgery (T2). In post-surgery rehabilitation, waist circumference increased in all participants when comparing T3 and T4. Regarding T4, participants 1, 2, 3, and 5 had lower values with respect to baseline (Table 3).
In terms of hip circumference, the only participant who did not reduce their perimeter was participant 1. T3 and T4 followed a similar trend recovering similar values to baseline, with the exception of participant 2 (Table 3),
In general, all participants presented similar values of visceral fat levels in T2, T3 and T4 with respect to T1, with the lowest values after surgery (7.4) (Table 3).
All participants lost body weight and body fat percentage during the prehabilitation phase and after surgery but increased slightly at T4. Body weight declined from 78.24 kg (T1) to 76.52 kg (T2) and 73.68 kg (T3), followed by partial recovery to 75.7 kg at T4, while body fat percentage decreased from 22.34% (T1) to 22.28% (T2) and 21.18% (T3), with a slight increase to 21.82% at T4 (Table 3).
As shown in Table 3, only muscle mass of participant 3 increased during the prehabilitation phase but after surgery, all participants showed lower values with respect to baseline. In general, muscle mass decreased from 58.1 kg (T1) to 56.52 kg (T2) and 55.28 kg (T3), with partial recovery to 56.64 kg at T4, although only participant 4 returned to baseline levels (Table 3).
  • Muscle Strength
Handgrip strength improved in the dominant and non-dominant hands in prehabilitation phase, increasing from a mean of 33.6 ± 13.8 kg at T1 to 38.4 ± 15.7 kg at T2 for the dominant hand and 30.0 ± 11.0 kg (T1) to 34.4 ± 12.4 kg (T2) for the non-dominant hand. Considering post-surgery, only participants 2 and 4 increased handgrip strength in both hands. However, at T4 all participants showed higher values compared to baseline except for participant 4 for the dominant hand (Table 4).
Lower limb strength, as measured by 5R-STS, also showed functional improvements in all participants at T2. The mean completion time improved from 10.87 ± 2.92 seconds at T1 to 8.53 ± 2.37 seconds at T2. After surgery (T3), participants 2 and 5 had the worst values compared to T1 but all participants showed better values at T4 compared to baseline (8.45 ± 2.18 s) (Table 4).
  • Psychosocial factors
Psychosocial adaptation varied among participants in the different dimensions (Table 5).
Regarding the Fighting Spirit dimension, all participants remained relatively stable over time except for participant 2, who showed lower values after intervention. Results for the Anxious Preoccupation dimension showed an increase for all participants in T4 and T5. For the Fatalism dimension, participants 2, 3, and 4 increased their scores at T4, but at T5, only participants 2 and 3 maintained their scores. Participants 1, 2, and 4 increased their scores on the Helplessness/Hopelessness dimension at T4, but in follow-up (T5), participants 1 and 2 maintained their scores. In the Cognitive Avoidance dimension, all participants except participant 1 had higher scores at T4 and T5 (Table 5).
Psychological distress, as measured by the Hospital Anxiety and Depression Scale (HADS) (Table 6), showed a favourable evolution over the course of the intervention. Although participant 1 increased his score by 1 point, anxiety levels (HADS-A) decreased significantly from 10.2 ± 4.79 at baseline (T1) to 7.2 ± 4.26 at both T4 and T5 (−3.0 points). Similarly, depression scores (HADS-D) decreased from 7.4 ± 3.13 to 6.0 ± 1.22 (−1.4 points), with participants 1 and 2 showing higher values at T4 and T5.
  • Health-related quality of life (HRQoL)
The EQ-5D index showed minimal differences between the participants along the prehabilitation and post-surgery rehabilitation (Table 7).
During prehabilitation, the total scores of patient’s health state varied from 0.973 (T1) to 0.958 (T2), with participant 2's pain/discomfort scores worsening. After surgery, all participants' scores worsened at T3 but improved during postoperative rehabilitation (T4) and remained stable at follow-up (T5).
In contrast, the EQ Visual Analogue Scale (VAS), which captures subjective self-rated health, revealed a more dynamic pattern. Mean VAS scores improved slightly after prehabilitation (T1: 77.0 ± 13.04; T2: 79 ± 10.84), followed by a marked decline post-surgery (T3: 58 ± 8.37). Partial recovery was observed during the post-surgery rehabilitation phase (T4: 68.8 ± 27.80), which continued to a modest extent at follow-up (T5: 67 ± 18.57), although baseline values were not reached (Table 7).

3. Discussion

This case series examines the quantitative changes in functional capacity, body composition, muscle strength, psychosocial adjustment and QoL in five patients who underwent laparoscopic CCR surgery and subsequently participated in an asynchronous multimodal telerehabilitation program.
During the prehabilitation phase, participants showed an increase in distance walked during the 6MWT, with further significant improvements observed post-rehabilitation assessment. The improvement was above the threshold of 50 meters, which is the minimum detectable change (MDC) in patients with similar characteristics to those in our study[26]. These changes align with findings from Beyer et al., who reported a pooled mean increase of 63.47 meters (95% CI 28.18–98.76) in postoperative cancer patients undergoing structured exercise interventions [15]. Yang et al. similarly identified moderate-quality evidence supporting improved physical fitness following exercise-based rehabilitation in CRC patients [42] .
Similarly, handgrip strength in both the dominant and non-dominant hands increased during the prehabilitation phase, with slight improvements observed post-rehabilitation. Only one patient exceeded the MDC of 6.5 kg and maintained this improvement pre-rehabilitation; however, the improvement achieved decrease post-rehabilitation. In addition, the 5R-STS showed a reduction post-rehabilitation, indicating a measurable improvement in lower limb performance, however, none of the patients reached the MDC.
The improvements in handgrip strength and lower limb performance observed in our study are consistent with the results of previous studies on prehabilitation and telerehabilitation interventions. Pesce et al. showed that prehabilitation can significantly improve functional recovery after CCR surgery, with measurable improvements in physical performance parameters [43]. Similarly, Piraux et al. reported that structured preoperative interventions in high-risk surgical patients resulted in modest but clinically relevant improvement muscle strength and overall functional capacity [44].Although only one patient in our study exceeded the MDC in handgrip strength and none reached the MDC for lower limb performance as measured by the 5R-STS, these results nevertheless suggest that telerehabilitation may induce quantifiable improvements in physical performance [35]. Overall, these studies highlight the potential benefits of incorporating preoperative conditioning strategies, but also highlight that further research is required to confirm the clinical effectiveness of such interventions.
Regarding body composition, there was a modest reduction in waist circumference and weight at post-prehabilitation and post-rehabilitation. Muscle mass and body fat percentage also decreased. While these results may seem contradictory, particularly the loss of muscle mass, they are consistent with previous studies indicating that short-term multimodal interventions can lead to body recomposition, depending on baseline nutritional status, adherence, and the balance between aerobic and resistance training components [45,46]. Bojesen et al. highlighted that high-intensity prehabilitation may improve functional outcomes even when changes in body composition are minimal [47], while Carli et al. found that multimodal prehabilitation could modulate lean body mass, especially when combined with nutritional support [48]. The muscle loss observed in some participants could be due to surgical stress, reduced caloric intake or an inadequate anabolic stimulus during the intervention, emphasizing the need for ongoing nutritional monitoring and resistance-focused programming in future iterations [49].
Psychosocial outcomes, as measured by the MAC scale and the HADS, which are typically associated with active coping, remained relatively stable in most patients. On the MAC scale, dimensions associated with active coping, such as “Fighting Spirit,” remained relatively stable throughout the intervention. However, the deterioration in some patients indicated emotional fatigue or a diminished sense of agency over the course of treatment [36]. In contrast, the “Anxious Preoccupation” subscale increased consistently during rehabilitation and follow-up, indicating increased concern about disease recurrence or postoperative outcomes [37]. This pattern mirrors the findings of Wu et al. who observed increased pre-surgical anxiety despite engagement in home-based prehabilitation programs [50]. Such discrepancies between internal coping mechanisms and perceived anxiety may indicate a need for more targeted psychological interventions embedded within telerehabilitation models [39].
Interestingly, the HADS scores revealed a contrasting trend: both anxiety and depression scores decreased during the intervention timeline, suggesting an overall improvement in emotional well-being. These findings are consistent with reports by González-Saenz de Tejada et al. and Józwik et al. who documented psychological improvements following structured rehabilitation programs, including telehealth-delivered formats [51,52]. This apparent discrepancy between general distress and cancer-specific adaptation underscores the multidimensional nature of psychosocial responses in oncology contexts.
With regard to HRQoL, which was assessed using the EQ-5D index and the EQ-VAS, there was general stability across the time points. The EQ-5D index remained consistently high, suggesting that participants maintained their ability to perform daily activities and experienced no major impairment in functional health [53]. These findings are consistent with those of Downing et al. who reported that although one-third of colorectal cancer survivors rated their health as perfect on the EQ-5D index, the majority still experienced problems, particularly with pain/discomfort and usual activities, which were also temporarily observed post-surgery [54]. In contrast, the EQ-VAS, which reflects patients’ subjective perception of health, showed greater variability: a slight improvement after prehabilitation, a significant decline after surgery and only partial recovery at follow-up [55]. Nonetheless, these results also highlight the importance of integrating symptom management and psychosocial support within telerehabilitation models to more fully restore perceived QoL [41].
This case series illustrates the practical application of an asynchronous telerehabilitation model in a CCR patient population. Unlike most prehabilitation programs, which are delivered in person or via synchronous online sessions, this approach empowered patients to self-manage their intervention using a digital platform supported by remote monitoring. Despite varying outcomes, all participants successfully completed the program, suggesting that this model offers greater accessibility, particularly for those facing geographic, time or mobility challenges [56].
Although the preliminary nature of this case series limits definitive conclusions regarding efficacy and generalizability, the results provide valuable insight into the development of functional, physical, and psychosocial parameters over time in the context of telerehabilitation. Limitations of the study include the small sample size, the lack of a control group, and the lack of stratification by tumor type, treatment phase, or comorbidities, all of which may have contributed to the variability in baseline values. Nevertheless, the observed changes suggest that the telerehabilitation model is not only feasible but also potentially sensitive enough to detect trends within patients. A notable strength of this study is the comprehensive, multidimensional follow-up with validated measures across five time points, allowing for a nuanced representation of temporal trends throughout the perioperative period.
Further research is needed to explore patient-reported barriers and facilitators to engagement and to optimize personalization and monitoring of digital interventions in cancer surgery. These preliminary results can serve as a basis for the design of future randomized controlled trials with sufficient power to assess both clinical outcomes and cost-effectiveness.

4. Conclusion

This case series provides initial evidence of integrating an asynchronous telerehabilitation program into the prehabilitation and rehabilitation continuum for patients undergoing laparoscopic colorectal cancer surgery. Moderate and variable improvements in physical performance, body composition, muscle strength, psychosocial outcomes and health-related quality of life were observed in all five cases. The asynchronous delivery model, which promotes patient self-management supported by remote monitoring, represents a potentially valuable alternative to conventional rehabilitation strategies. However, given the exploratory nature of these results, further research is needed to determine clinical effectiveness, optimize intervention components, and evaluate the cost-effectiveness of telerehabilitation within oncology treatment pathways.

Author Contributions

JM.B.-B., C.J.-S. and S.C. have contributed to the conception of this study. JM.B.-B., B.C.-P., N.B.-C., C.J.-S. and S.C. were involved in the acquisition of data, or analysis and interpretation of data. JM.B.-B. writing—original draft preparation, B.C.-P., N.B.-C., C.J.-S, JL.B.-L., and S.C.-C writing—review and editing; All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki. the intervention has been approved by the Ethics Committee of Aragón (reference number: PI23/557; Acta Nº 23/2023).

Informed Consent Statement

Informed consent was obtained from the subjects involved in the study. Written informed consent has been obtained from the patients to publish this paper.

Data Availability Statement

The data supporting the findings of this study have been provided for review. Due to privacy and protection concerns, the data cannot be made publicly accessible. This measure ensures the confidentiality and security of sensitive information. For this reason, the raw data will be available upon request from the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
CRC Colorectal Cancer
WHO World Health Organization
QoL Quality of Life
ERAS Enhanced Recovery After Surgery
ASA American Society of Anaesthesiologists
BMI Body Mass Index
6MWT Six-Minute Walk Test
ATS American Thoracic Society
ERS European Respiratory Society
BIA Bioelectrical Impedance Analysis
HGS Handgrip Strength Test
5R-STS Five-Repetition Sit-to-Stand Test
MAC Mental Adjustment to Cancer
HADS Hospital Anxiety and Depression Scale
HRQoL Health-Related Quality of Life
EQ-5D EuroQol-5D
EQ-VAS Visual Analogue Scale
T1 Pre-prehabilitation
T2 Post-prehabilitation
T3 Pre-rehabilitation
T4 Post-rehabilitation
T5 Follow-up
FS Fighting Spirit
AP Anxious Preoccupation
FA Fatalism
HH Helplessness/Hopelessness
CA Cognitive Avoidance
MDC Minimum Detectable Change

References

  1. Roshandel, G.; Ghasemi-Kebria, F.; Malekzadeh, R. Colorectal Cancer: Epidemiology, Risk Factors, and Prevention. Cancers (Basel) 2024, 16. [Google Scholar] [CrossRef] [PubMed]
  2. Siegel, R.L.; Wagle, N.S.; Cercek, A.; Smith, R.A.; Jemal, A. Colorectal cancer statistics, 2023. CA Cancer J Clin 2023, 73, 233–254. [Google Scholar] [CrossRef] [PubMed]
  3. Vainio, H.; Miller, A.B. Primary and Secondary Prevention in Colorectal Cancer. Acta Oncol (Madr) 2003, 42, 809–815. [Google Scholar] [CrossRef] [PubMed]
  4. Li, Q.; Geng, S.; Luo, H.; Wang, W.; Mo, Y.-Q.; Luo, Q.; et al. Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy. Signal Transduct Target Ther 2024, 9, 266. [Google Scholar] [CrossRef]
  5. Wheelwright, S.; Permyakova, N.V.; Calman, L.; Din, A.; Fenlon, D.; Richardson, A.; et al. Does quality of life return to pre-treatment levels five years after curative intent surgery for colorectal cancer? Evidence from the ColoREctal Wellbeing (CREW) study. PLoS One 2020, 15. [Google Scholar] [CrossRef]
  6. Miyamoto, Y.; Hiyoshi, Y.; Tokunaga, R.; Akiyama, T.; Daitoku, N.; Sakamoto, Y.; et al. Postoperative complications are associated with poor survival outcome after curative resection for colorectal cancer: A propensity-score analysis. J Surg Oncol 2020, 122, 344–349. [Google Scholar] [CrossRef]
  7. Bojesen, R.D.; Grube, C.; Buzquurz, F.; Miedzianogora, R.E.G.; Eriksen, J.R.; Gögenur, I. Effect of modifying high-risk factors and prehabilitation on the outcomes of colorectal cancer surgery: controlled before and after study. BJS Open 2022, 6. [Google Scholar] [CrossRef]
  8. Pak, H.; Maghsoudi, L.H.; Soltanian, A.; Gholami, F. Surgical complications in colorectal cancer patients. Annals of Medicine and Surgery 2020, 55, 13–18. [Google Scholar] [CrossRef]
  9. Waterland, J.L.; McCourt, O.; Edbrooke, L.; Granger, C.L.; Ismail, H.; Riedel, B.; et al. Efficacy of Prehabilitation Including Exercise on Postoperative Outcomes Following Abdominal Cancer Surgery: A Systematic Review and Meta-Analysis. Front Surg 2021, 8. [Google Scholar] [CrossRef]
  10. Stout, N.L.; Santa Mina, D.; Lyons, K.D.; Robb, K.; Silver, J.K. A systematic review of rehabilitation and exercise recommendations in oncology guidelines. CA Cancer J Clin 2021, 71, 149–175. [Google Scholar] [CrossRef]
  11. Clinical practice guidelines for the prevention, early detection and management of colorectal cancer||References n.d. Available online: https://app.magicapp.org/#/guideline/noPKwE (accessed on 30 March 2025).
  12. Molenaar, C.J.L.; Minnella, E.M.; Coca-Martinez, M.; Cate DWG ten, Regis, M.; Awasthi, R.; et al. Effect of Multimodal Prehabilitation on Reducing Postoperative Complications and Enhancing Functional Capacity Following Colorectal Cancer Surgery: The PREHAB Randomized Clinical Trial. JAMA Surg 2023, 158, 572–581. [CrossRef]
  13. Carli, F.; Bousquet-Dion, G.; Awasthi, R.; Elsherbini, N.; Liberman, S.; Boutros, M.; et al. Effect of Multimodal Prehabilitation vs Postoperative Rehabilitation on 30-Day Postoperative Complications for Frail Patients Undergoing Resection of Colorectal Cancer: A Randomized Clinical Trial. JAMA Surg 2020, 155, 233–242. [Google Scholar] [CrossRef] [PubMed]
  14. Yang, M.; Amatya, B.; Malik, S.; Song, K.; Marcella, S.; Voutier, C.; et al. Effectiveness of rehabilitation interventions in patients with colorectal cancer: an overview of systematic reviews. J Rehabil Med 2025, 57, jrm40021. [Google Scholar] [CrossRef] [PubMed]
  15. Beyer, M.; Bischoff, C.; Lässing, J.; Gockel, I.; Falz, R. Effects of postoperative physical exercise rehabilitation on cardiorespiratory fitness, functional capacity and quality of life in patients with colorectal, breast, and prostate cancer – a systematic review and meta-analysis. J Cancer Res Clin Oncol 2025, 151. [Google Scholar] [CrossRef]
  16. Trépanier, M.; Minnella, E.M.; Paradis, T.; Awasthi, R.; Kaneva, P.; Schwartzman, K.; et al. Improved Disease-free Survival after Prehabilitation for Colorectal Cancer Surgery. Ann Surg 2019, 270, 493–501. [Google Scholar] [CrossRef]
  17. Bojesen, R.D.; Dalton, S.O.; Skou, S.T.; Jørgensen, L.B.; Walker, L.R.; Eriksen, J.R.; et al. Preoperative multimodal prehabilitation before elective colorectal cancer surgery in patients with WHO performance status I or II: randomized clinical trial. BJS Open 2023, 7. [Google Scholar] [CrossRef]
  18. Choi, B.Y.; Bae, J.H.; Lee, C.S.; Han, S.R.; Lee, Y.S.; Lee, I.K. Implementation and improvement of Enhanced Recovery after Surgery protocols for colorectal cancer surgery. Ann Surg Treat Res 2022, 102, 223–233. [Google Scholar] [CrossRef]
  19. Peretti, A.; Amenta, F.; Tayebati, S.K.; Nittari, G.; Mahdi, S.S. Telerehabilitation: Review of the state-of-the-art and areas of application. JMIR Rehabil Assist Technol 2017, 4. [Google Scholar] [CrossRef]
  20. Winters, J.M. Telerehabilitation research: Emerging opportunities. Annu Rev Biomed Eng 2002, 4, 287–320. [Google Scholar] [CrossRef]
  21. Van Blarigan, E.L.; Chan, H.; Van Loon, K.; Kenfield, S.A.; Chan, J.M.; Mitchell, E.; et al. Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): A pilot randomized controlled trial. BMC Cancer 2019, 19. [Google Scholar] [CrossRef]
  22. Dennett, A.; Harding, K.E.; Reimert, J.; Morris, R.; Parente, P.; Taylor, N.F. Telerehabilitation’s Safety, Feasibility, and Exercise Uptake in Cancer Survivors: Process Evaluation. JMIR Cancer 2021, 7. [Google Scholar] [CrossRef] [PubMed]
  23. Larson, J.L.; Rosen, A.B.; Wilson, F.A. The effect of telehealth interventions on quality of life of cancer survivors: A systematic review and meta-analysis. Health Informatics J 2020, 26, 1060–1078. [Google Scholar] [CrossRef] [PubMed]
  24. Reese, C.; Weis, J.; Schmucker, D.; Mittag, O. Development of practice guidelines for psychological interventions in the rehabilitation of patients with oncological disease (breast, prostate, or colorectal cancer): Methods and results. Psychooncology 2017, 26, 1513–1518. [Google Scholar] [CrossRef]
  25. Holland, A.E.; Spruit, M.A.; Troosters, T.; Puhan, M.A.; Pepin, V.; Saey, D.; et al. An official European respiratory society/American thoracic society technical standard: Field walking tests in chronic respiratory disease. European Respiratory Journal 2014, 44, 1428–1446. [Google Scholar] [CrossRef] [PubMed]
  26. American Thoracic Society ATS Statement: Guidelines for the Six-Minute Walk Test T HIS O FFICIAL S TATEMENT OF THE A MERICAN T HORACIC S OCIETY WAS APPROVED BY THE ATS B OARD OF D IRECTORS M ARCH 2002 n.d. [CrossRef]
  27. Schmidt, K.; Vogt, L.; Thiel, C.; Jäger, E.; Banzer, W. Validity of the six-minute walk test in cancer patients. Int J Sports Med 2013, 34, 631–636. [Google Scholar] [CrossRef]
  28. Luz Alejandra Lorca, P.; Ribeiro, I.L.; Mónica Martínez, M.; Jorge Plasser, T.; Jessica Vivallos, G.; Roberto Salas, O. Functional results of a prehabilitation program in elective colorectal cancer surgery. Rev Cir (Mex) 2022, 74, 276–282. [Google Scholar] [CrossRef]
  29. Bohannon, R.W.; Crouch, R. Minimal clinically important difference for change in 6-minute walk test distance of adults with pathology: a systematic review. J Eval Clin Pract 2017, 23, 377–381. [Google Scholar] [CrossRef]
  30. Ræder, H.; Kværner, A.S.; Henriksen, C.; Florholmen, G.; Henriksen, H.B.; Bøhn, S.K.; et al. Validity of bioelectrical impedance analysis in estimation of fat-free mass in colorectal cancer patients. Clinical Nutrition 2018, 37, 292–300. [Google Scholar] [CrossRef]
  31. Branco, M.G.; Mateus, C.; Capelas, M.L.; Pimenta, N.; Santos, T.; Mäkitie, A.; et al. Bioelectrical Impedance Analysis (BIA) for the Assessment of Body Composition in Oncology: A Scoping Review. Nutrients 2023, 15. [Google Scholar] [CrossRef]
  32. Wang, N.; Khankari, N.K.; Cai, H.; Li, H.L.; Yang, G.; Gao, Y.T.; et al. Prediagnosis body mass index and waist–hip circumference ratio in association with colorectal cancer survival. Int J Cancer 2017, 140, 292–301. [Google Scholar] [CrossRef]
  33. Godinho, L.R.D.L.C.; Ribeiro, G.P.; Lopez, E.A.; Deminice, R. Handgrip strength test vs chair stand test: Divergent diagnosis of sarcopenia and its clinical implications in colorectal cancer. Clin Nutr ESPEN 2024, 63, 1068. [Google Scholar] [CrossRef]
  34. Bohannon, R.W. Minimal clinically important difference for grip strength: a systematic review. n.d.
  35. Muñoz-Bermejo, L.; Adsuar, J.C.; Mendoza-Muñoz, M.; Barrios-Fernández, S.; Garcia-Gordillo, M.A.; Pérez-Gómez, J.; et al. Test-retest reliability of five times sit to stand test (Ftsst) in adults: A systematic review and meta-analysis. Biology (Basel) 2021, 10. [Google Scholar] [CrossRef] [PubMed]
  36. Cayrou, S.; Dickès, P.; Gauvain-Piquard, A.; Rogé, B. The Mental Adjustment to Cancer (MAC) Scale: French replication and assessment of positive and negative adjustment dimensions. Psychooncology 2003, 12, 8–23. [Google Scholar] [CrossRef] [PubMed]
  37. Watson, M.; Homewood, J. Mental Adjustment to Cancer Scale©: Psychometric properties in a large cancer cohort. Psychooncology 2008, 17, 1146–1151. [Google Scholar] [CrossRef]
  38. Smith, A.B.; Selby, P.J.; Velikova, G.; Stark, D.; Wright, E.P.; Gould, A.; et al. Factor analysis of the hospital anxiety and depression scale from a large cancer population. Psychology and Psychotherapy: Theory, Research and Practice 2002, 75, 165–176. [Google Scholar] [CrossRef]
  39. Aminisani, N.; Nikbakht, H.; Jafarabadi, M.A.; Shamshirgaran, S.M. Depression, anxiety, and health related quality of life among colorectal cancer survivors. J Gastrointest Oncol 2017, 8, 81–88. [Google Scholar] [CrossRef]
  40. Roudijk, B.; Ludwig, K.; Devlin, N. EQ-5D-5L value set summaries. Value Sets for EQ-5D-5L: A Compendium, Comparative Review & User Guide, Springer International Publishing; 2022, p. 55–212. [CrossRef]
  41. Flyum, I.R.; Mahic, S.; Grov, E.K.; Joranger, P. Health-related quality of life in patients with colorectal cancer in the palliative phase: a systematic review and meta-analysis. BMC Palliat Care 2021, 20. [Google Scholar] [CrossRef]
  42. Yang, M.; Amatya, B.; Malik, S.; Song, K.; Marcella, S.; Voutier, C.; et al. Effectiveness of rehabilitation interventions in patients with colorectal cancer: an overview of systematic reviews. J Rehabil Med 2025, 57, jrm40021. [Google Scholar] [CrossRef]
  43. Pesce, A.; Fabbri, N.; Colombari, S.; Uccellatori, L.; Grazzi, G.; Lordi, R.; et al. A randomized controlled clinical trial on multimodal prehabilitation in colorectal cancer patients to improve functional capacity: preliminary results. Surg Endosc 2024. [CrossRef]
  44. Piraux, E.; Caty, G.; Reychler, G. Effects of preoperative combined aerobic and resistance exercise training in cancer patients undergoing tumour resection surgery: A systematic review of randomised trials. Surg Oncol 2018, 27, 584–594. [Google Scholar] [CrossRef]
  45. Suen, M.; Liew, A.; Turner, J.D.; Khatri, S.; Lin, Y.; Raso, K.L.; et al. Short-term multimodal prehabilitation improves functional capacity for colorectal cancer patients prior to surgery. Asia Pac J Clin Oncol 2022, 18, e103–10. [Google Scholar] [CrossRef] [PubMed]
  46. Minnella, E.M.; Carli, F. Prehabilitation and functional recovery for colorectal cancer patients. European Journal of Surgical Oncology 2018, 44, 919–926. [Google Scholar] [CrossRef] [PubMed]
  47. Bojesen, R.D.; Dalton, S.O.; Skou, S.T.; Jørgensen, L.B.; Walker, L.R.; Eriksen, J.R.; et al. Preoperative multimodal prehabilitation before elective colorectal cancer surgery in patients with WHO performance status I or II: randomized clinical trial. BJS Open 2023, 7. [Google Scholar] [CrossRef] [PubMed]
  48. Carli, F.; Charlebois, P.; Stein, B.; Feldman, L.; Zavorsky, G.; Kim, D.J.; et al. Randomized clinical trial of prehabilitation in colorectal surgery. British Journal of Surgery 2010, 97, 1187–1197. [Google Scholar] [CrossRef]
  49. Van Rooijen, S.; Carli, F.; Dalton, S.; Thomas, G.; Bojesen, R.; Le Guen, M.; et al. Multimodal prehabilitation in colorectal cancer patients to improve functional capacity and reduce postoperative complications: The first international randomized controlled trial for multimodal prehabilitation. BMC Cancer 2019, 19. [Google Scholar] [CrossRef]
  50. Fiona, W.; Oloruntobi, R.; Roberto, L.C.; Tarannum, R. The feasibility and effects of a telehealth-delivered home-based prehabilitation program for cancer patients during the pandemic. Current Oncology 2021, 28, 2248–2259. [Google Scholar] [CrossRef]
  51. Gonzalez-Saenz de Tejada, M.; Bilbao, A.; Baré, M.; Briones, E.; Sarasqueta, C.; Quintana, J.M.; et al. Association between social support, functional status, and change in health-related quality of life and changes in anxiety and depression in colorectal cancer patients. Psychooncology 2017, 26, 1263–1269. [Google Scholar] [CrossRef]
  52. Jóźwik, S.; Cieślik, B.; Gajda, R.; Szczepańska-Gieracha, J. Evaluation of the impact of virtual reality-enhanced cardiac rehabilitation on depressive and anxiety symptoms in patients with coronary artery disease: A randomised controlled trial. J Clin Med 2021, 10. [Google Scholar] [CrossRef]
  53. Zhang, X.; Liu, J.; Zhu, H.; Zhang, X.; Jiang, Y.; Zhang, J. Effect of Psychological Intervention on Quality of Life and Psychological Outcomes of Colorectal Cancer Patients. Psychiatry (New York) 2020, 83, 58–69. [Google Scholar] [CrossRef]
  54. Downing, A.; Morris, E.J.A.; Richards, M.; Corner, J.; Wright, P.; Sebag-Montefiore, D.; et al. Health-related quality of life after colorectal cancer in England: A patient-reported outcomes study of individuals 12 to 36 months after diagnosis. Journal of Clinical Oncology 2015, 33, 616–624. [Google Scholar] [CrossRef]
  55. Mishra, S.I.; Scherer, R.W.; Snyder, C.; Geigle, P.M.; Berlanstein, D.R.; Topaloglu, O. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database of Systematic Reviews 2012, 2012. [Google Scholar] [CrossRef]
  56. Carpallo-Porcar, B.; Romo-Calvo, L.; Perez-Palomares, S.; Jimenez-Sanchez, C.; Herrero, P.; Brandin-De la Cruz, N.; et al. Efficacy of an asynchronous telerehabilitation program in post-COVID-19 patients: A protocol for a pilot randomized controlled trial. PLoS One 2022, 17. [Google Scholar] [CrossRef] [PubMed]
Table 1. Sociodemographic characteristics.
Table 1. Sociodemographic characteristics.
Age Gender Weight (kg) Height (cm) BMI (kg/cm) Marital Status Education Level Employment Status
Participant 1 36 Male 92.8 191 25.7 Single Secondary Employed
Participant 2 62 Female 56.9 166 20.6 Divorced Primary Employed
Participant 3 52 Female 53.4 164 20.8 Divorced University Employed
Participant 4 56 Male 95.6 179 29.8 Married Secondary Employed
Participant 5 62 Male 92.5 179 28.9 Married University Employed
BMI = Body Mass Index
Table 2. Submaximal Functional Capacity.
Table 2. Submaximal Functional Capacity.
Variable Participant Assessment Change Score
T1 T2 T3 T4 T2-T1 T3-T1 T4-T1
6MWT
(meters)
P1 600 690 615 670 90 -75 70
P2 570 660 400 540 90 -170 -30
P3 480 720 660 770 240 180 290
P4 550 630 554 630 80 4 80
P5 586 680 514 570 94 -72 -16
Mean ±SD 557.0 ± 47 676.0 ± 33.6 548.6 ± 100.2 652.5 ± 90.4 67.9 ± 118.8 130.9 ± 26.6 128.0 ± 78.8
Table 3. Body composition.
Table 3. Body composition.
Variable Participant Assessment Change Score
T1 T2 T3 T4 T2-T1 T3-T1 T4-T1
Waist Circumference (cm) P1 94 92 90 92 -2 -4 -2
P2 72 72 72 74 0 0 2
P3 75 71 70 73 -4 -5 -2
P4 109 105.5 103 105 -3.5 -6 -4
P5 102 100 98 99 -2 -4 -3
Mean ±SD 90.4 ± 16.3 83.8 ± 16.3 86.6 ± 15 88.6 ± 14.5 (-) 2.3 ± 1.6 (-) 3.8 ± 2.3 (-) 1.8 ± 2.3
Hip Circumference (cm) P1 106 106 106 106 0 0 0
P2 99 91 92.5 94 -8 -6.5 -5
P3 93 89 92.5 93 -4 -0.5 0
P4 105 104.5 104 104 -0.5 -1 -1
P5 106 105 104 106 -1 -2 0
Mean ±SD 101.8 ± 5.7 97.8 ± 9 104.7 ± 1.2 100.6 ± 6.5 (-) 2.7 ± 3.3 (-) 2.0 ± 2.6 (-) 1.2 ± 2.2
Visceral Fat Level P1 5 5 5 5 0 0 0
P2 6 6 5 6 0 -1 0
P3 4 4 3 4 0 -1 0
P4 12 13 12 10 1 0 -2
P5 13 14 12 16 1 -1 2
Mean ±SD 8 ± 4.2 8.4 ± 4.7 7.4 ± 4.3 8.2 ± 4.9 0.4 ± 0.5 (-) 0.6 ± 0.5 0 ± 1.4
Weight (kg) P1 92.8 89.2 86.8 90.6 -3.6 -6 -2.2
P2 56.9 56.1 54.2 55.7 -0.8 -2.7 -1.2
P3 53.4 52.5 50.9 51.4 -0.9 -2.5 -3
P4 95.6 94.5 89.1 90.5 -1.1 -6.5 -5.1
P5 92.5 90.3 87.4 90.3 -2.2 -5.1 -2.2
Mean ±SD 78.2 ± 22.6 76.5 ± 21.8 73.7 ± 20.5 875.7 ± 21.4 (-) 1.7 ± 1.2 (-) 4.6 ± 1.9 (-) 2.7 ± 1.5
Body Fat (Percentage) P1 14.7 15.1 15 14.8 0.4 0.3 0.1
P2 26.1 26.3 26.5 26.4 0.2 0.4 0.3
P3 23.5 20.5 20.4 23.1 -3 -3.1 -0.4
P4 23.2 24.2 24.1 18.8 1 0.9 -4.4
P5 24.2 25.3 22.9 26 1.1 -1.3 1.8
Mean ±SD 24.5 ± 1.5 22.3 ± 4.6 21.8 ± 4.4 21.8 ± 5 (-) 0.1 ± 1.7 (-) 0.6 ± 1.6 (-) 0.5 ± 2.3
Muscle Mass (Percentage) P1 75.3 72 70.2 73.4 -3.3 -5.1 -1.9
P2 39.9 39.0 39.4 38.9 -0.9 -0.5 -1
P3 38.7 39.2 38.5 37.6 0.5 -0.2 -1.1
P4 69.9 68.1 64.2 69.8 -1.8 -5.7 -0.1
P5 66.7 64.1 64.1 63.5 -2.6 -2.6 -3.2
Mean ±SD 58.1 ± 17.4 60.9 ± 14.8 55.3 ± 15.1 56.6 ± 17.2 (-) 1.6 ± 1.5 (-) 2.8 ± 2.5 (-) 1.5 ± 1.2
BMI (Body Mass Index) P1 25.7 24.7 24.3 24.8 -1 -1.4 -0.9
P2 20.6 20.4 19.9 20.2 -0.2 -0.7 -0.4
P3 20.8 20.5 19.9 20.1 -0.3 -0.9 -0.7
P4 29.8 29.5 27.8 28.2 -0.3 -2.3 -1.6
P5 28.9 28.5 27.3 27.8 -0.4 -1.6 -1.1
Mean ±SD 25.2 ± 4.3 24.7 ± 4.3 23.8 ± 3.8 24.2 ± 3.9 (-) 0.4 ± 0.3 (-) 1.4 ± 0.6 (-) 0.9 ± 0.5
T1: pre-prehabilitation; T2: post-prehabilitation; T3: pre-rehabilitation; T4: post-rehabilitation; T5: follow-up.
Table 4. Muscle strength.
Table 4. Muscle strength.
Variable Participant Assessment Change Score
T1 T2 T3 T4 T2–T1 T3–T1 T4–T1
Handgrip Strength Dominant(kg) P1 45 48 45 48 3 0 3
P2 19 26 26 22 7 7 3
P3 20 20 21 22 0 1 2
P4 35 35 35 34 0 0 -1
P5 49 55 47 50 6 -2 1
Mean ± SD 33.6 ± 13.8 36.8 ± 14.7 34.8 ± 11.4 35.2 ± 13.5 3.2 ± 3.3 1.2 ± 3.4 1.6 ± 1.7
Handgrip Strength Non-dominant (kg) P1 40 41 38 41 1 -2 1
P2 18 22 21 20 4 3 2
P3 22 22 19 23 0 -3 1
P4 27 33 28 30 5 1 3
P5 43 46 40 44 3 -3 1
Mean ± SD 30.0 ± 11 32.8 ± 10.9 29.2 ± 9.6 31.6 ± 10.6 2.6 ± 2.1 (-) 0.8 ± 2.7 1.6 ± 0.9
Sit-to-stand5R-STS (s) P1 13.09 10.84 11.5 9.84 -2.25 -1.59 -3.25
P2 10.72 10.63 14.94 9.78 -0.09 4.22 -0.94
P3 8.37 6.8 7.25 5.85 -1.57 -1.12 -2.52
P4 11.46 7.46 10.1 10.46 -4 -1.36 -1
P5 7.69 6.28 8.69 6.34 -1.41 1 -1.35
Mean ± SD 10.3 ± 2.2 7.8 ± 2 10.5 ± 2.9 8.5 ± 2.2 1.9 ± 1.4 0.2 ± 2.5 (-) 1.8 ± 1
T1: pre-prehabilitation; T2: post-prehabilitation; T3: pre-rehabilitation; T4: post-rehabilitation; T5: follow-up.
Table 5. Psychosocial factors: The Mental Adjustment to Cancer Scale (MAC).
Table 5. Psychosocial factors: The Mental Adjustment to Cancer Scale (MAC).
Variable Participant Assessment Change Score
T1 T4 T5 T4-T1 T5-T1
Fighting Spirit (FS) P1 30 31 31 1 1
P2 34 28 28 -6 -6
P3 24 26 26 -2 -2
P4 29 31 29 2 0
P5 29 28 28 -1 -1
Mean ± SD 29.2 ± 3.6 28.8 ± 2.2 28.4 ± 1.8 (-) 1.0 ± 3.6 (-) 1.5 ± 3.1
Anxious Preoccupation (AP) P1 19 21 21 2 2
P2 19 22 22 3 3
P3 19 23 23 4 4
P4 16 21 20 5 4
P5 19 26 26 7 7
Mean ± SD 18.4 ± 1.3 22.6 ± 2.1 22.4 ± 2.3 4.2 ± 1.9 4.0 ± 1.9
Fatalism (FA) P1 24 16 16 -8 -8
P2 17 18 18 1 1
P3 11 13 13 2 2
P4 15 17 14 2 -1
P5 19 15 15 -4 -4
Mean ± SD 17.2 ± 4.8 15.8 ± 1.9 15.2 ± 1.9 (-) 1.4 ± 4.4 (-) 2.0 ± 4.1
Helplessness/Hopelessness (HH) P1 22 25 25 3 3
P2 22 24 24 2 2
P3 30 27 27 -3 -3
P4 23 27 23 4 0
P5 26 25 25 -1 -1
Mean ± SD 24.6 ± 3.4 25.6 ± 1.3 24.8 ± 1.5 1.0 ± 2.9 0.2 ± 2.4
Cognitive Avoidance (CA) P1 8 7 7 -1 -1
P2 5 7 7 2 2
P3 5 7 7 2 2
P4 6 7 7 1 1
P5 6 7 7 1 1
Mean ± SD 6.0 ± 1.2 7.0 ± 0 7.0 ± 0 1.0 ± 1.2 1.0 ± 1.2
T1: pre-prehabilitation; T2: post-prehabilitation; T3: pre-rehabilitation; T4: post-rehabilitation; T5: follow-up.
Table 6. Psychosocial factors: Hospital Anxiety and Depression Scale (HADS).
Table 6. Psychosocial factors: Hospital Anxiety and Depression Scale (HADS).
Variable Participant Assessment Change Score
T1 T4 T5 T4-T1 T5-T1
HADS-A P1 4 5 5 1 1
P2 13 9 9 -4 -4
P3 14 13 13 -1 -1
P4 5 3 3 -2 -2
P5 15 6 6 -9 -9
Mean ± SD 10.2 ± 5.3 7.2 ± 3.9 7.2 ± 3.9 (-) 3.0 ± 3.8 (-) 3.0 ± 3.8
HADS-D P1 6 7 7 1 1
P2 4 5 5 1 1
P3 12 7 7 -5 -5
P4 5 5 5 0 0
P5 10 6 6 -4 -4
Mean ± SD 7.4 ± 3.4 6.0 ± 1 6.0 ± 1 (-) 1.4 ± 2.9 (-) 1.4 ± 2.9
T1: pre-prehabilitation; T4: post-rehabilitation; T5: follow-up.
Table 7. Quality of life: EuroQol-5D.
Table 7. Quality of life: EuroQol-5D.
T1
Participant Mobility Self-care Usual Activities Pain/discomfort Anxiety / Depression EQ-5D index EQ-VAS
P1 1 1 1 1 1 1.000 60
P2 1 1 1 1 1 1.000 80
P3 1 1 1 1 2 0.932 70
P4 1 1 1 1 1 1.000 80
P5 1 1 1 1 2 0.932 95
Mean ± SD 0.973 ± 0.04 77.0 ± 13.04
T2
Participant Mobility Self-care Usual Activities Pain/discomfort Anxiety / Depression EQ-5D index EQ-VAS
P1 1 1 1 2 1 0.924 65
P2 1 1 1 1 1 1.000 80
P3 1 1 1 1 2 0.932 75
P4 1 1 1 1 1 1.000 80
P5 1 1 1 1 2 0.932 95
Mean ± SD 0.958 ± 0.04 79.0 ± 10.84
T3
Participant Mobility Self-care Usual Activities Pain/discomfort Anxiety / Depression EQ-5D index EQ-VAS
P1 1 1 1 2 1 0.924 60
P2 1 1 2 2 1 0.849 50
P3 1 1 1 1 2 0.932 50
P4 1 1 1 2 2 0.857 70
P5 1 1 1 1 1 1.000 60
Mean ± SD 0.912 ± 0.06 58.0 ± 8.37
T4
Participant Mobility Self-care Usual Activities Pain/discomfort Anxiety / Depression EQ-5D index EQ-VAS
P1 1 1 1 1 1 1.000 40
P2 1 1 1 1 2 0.932 50
P3 1 1 1 1 2 0.932 40
P4 1 1 1 2 2 0.857 90
P5 1 1 1 1 1 1.000 95
Mean ± SD 0.944 ± 0.06 68.8 ± 27.80
T5
Participant Mobility Self-care Usual Activities Pain/discomfort Anxiety / Depression EQ-5D index EQ-VAS
P1 1 1 1 1 1 1.000 50
P2 1 1 1 1 2 0.932 70
P3 1 1 1 1 2 0.932 50
P4 1 1 1 2 2 0.857 70
P5 1 1 1 1 1 1.000 95
Mean ± SD 0.944 ± 0.06 67.0 ± 18.57
T1: pre-prehabilitation; T2: post-prehabilitation; T3: pre-rehabilitation; T4: post-rehabilitation; T5: follow-up.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated